By Aveva Drug Delivery Systems
(Approved in the US, Canada and Latin America) - This Nicotine Transdermal System delivers 21mg, 14mg and 7mg respectively of nicotine over a 24 hour period. Indicated for smoking cessation, it reduces withdrawal symptoms, including nicotine cravings associated with quitting smoking.
Please contact us for more information.
Related Intelligence and Suppliers
White Papers
Enabling Drug Delivery Deal Making
Aveva Drug Delivery Systems
White Papers
Identifying Parameters of Value
Aveva Drug Delivery Systems
White Papers
Latest Products
Suppliers
Production & Manufacturing
Fine & Speciality Chemicals
Manufacturing
Process & Production
OTC
Drug Research Drug Delivery Drug Discovery & Development
Contract Research & Services Clinical Trials Contract Research Contract Services
Automation IT & Software Laboratory Instrumentation
Inward Investment Packaging Regulatory Affairs
Drug Research Drug Delivery Drug Discovery & Development
Contract Research & Services Clinical Trials Contract Research Contract Services
Automation IT & Software Laboratory Instrumentation
Inward Investment Packaging Regulatory Affairs
